跳转至内容
Merck
CN

30553

钐(III) 离子载体 I

Selectophore

别名:

格列吡嗪, 1-环己基-3-{4-[2-(5-甲基吡嗪-2-甲酰胺基)乙基]苯磺酰基}脲

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C21H27N5O4S
化学文摘社编号:
分子量:
445.54
UNSPSC Code:
26111700
PubChem Substance ID:
EC Number:
249-427-6
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

ZJJXGWJIGJFDTL-UHFFFAOYSA-N

InChI

1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)

SMILES string

Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3

product line

Selectophore

General description

请访问 传感器应用门户网站 了解更多信息。

Other Notes

EDTA 的电位滴定 Sm(III) 的指示电极

Legal Information

Selectophore is a trademark of Merck KGaA, Darmstadt, Germany

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

M.R. Ganjali et al.
Sensors and Actuators B, Chemical, 89, 21-21 (2003)
Ning Li et al.
Biomedical chromatography : BMC, 27(2), 191-196 (2012-07-06)
A selective, sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was developed and validated to determine metformin and glipizide simultaneously in human plasma using phenacetin as internal standard (IS). After one-step protein precipitation of 200 μL plasma with
D F Pereira et al.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 19(10), 868-877 (2012-07-17)
In this study we examined the acute in vivo effect and short- and long-term in vitro effects of samples from native and commercial Ilex paraguariensis on glucose homeostasis. Also, the potential effect of I. paraguariensis on serum insulin secretion was
Karl J Krobot et al.
Current medical research and opinion, 28(8), 1281-1287 (2012-06-16)
In a previously-published study, adding sitagliptin or glipizide to ongoing metformin therapy provided similar HbA(1c) improvement (both groups, -0.7%) after 52 weeks in patients with type 2 diabetes (T2DM). Significantly fewer patients experienced symptomatic hypoglycemia with sitagliptin (5% of 588
K M Pantalone et al.
Diabetic medicine : a journal of the British Diabetic Association, 29(8), 1029-1035 (2012-01-18)
Sulfonylureas have been shown to increase mortality when used in combination with metformin. This may not be a class effect of sulfonylureas, but rather secondary to differences in properties inherent to the individual sulfonylureas (hypoglycaemic risk, sulfonylurea receptor selectivity and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持